Update on COVID-19 and the race to develop a vaccine

 August 24, 2020 |Elizabeth (Libby) Hunter
Good morning – Below I’ve provided a link to the August 20th interview with Dr. Kennen MacKay, Managing Director and Co-Head of Biotechnology Research for RBC Capital Markets and Janet Engels, Head of the U.S. Portfolio Advisory Group, wherein they discuss...
Read more

What Lies Ahead for the Last Quarter of 2020?

 August 05, 2020 |Elizabeth (Libby) Hunter
Now that’s it’s August, I find my thoughts drifting toward the fall but also looking back and marveling at the resilience of the markets since the end of March. Much of the gains since then have had to do with unprecedented global monetary and fiscal...
Read more